Condition: Diabetes Mellitus, Type 2 · Sponsor: Novo Nordisk A/S
This study compares insulin icodec, taken once a week, with other basal insulins, taken once a day, in people with type 2 diabetes.The purpose of this study is to see how well the approved injectable weekly insulin icodec maintains blood sugar levels when compared to approved and available daily injectable basal insulins in people with type 2 diabetes. The participants will either be prescribed weekly insulin icodec or a daily basal insulin (insulin glargine, insulin detemir or insulin degludec) based on current standards for the treatment of type 2 diabetes. The study will last for about 13 months.
This description comes directly from the study's public registry record.
Novo Nordisk · (+1) 866-867-7178 · clinicaltrials@novonordisk.com
Always discuss trial participation with your own doctor first.
| Centricity Research Calgary Endocrinology | Calgary, Alberta, Canada | Recruiting |
| Alta Clinical Research at Hermitage Medicentre | Edmonton, Alberta, Canada | Recruiting |
| Fraser Clinical Trials Inc. | New Westminster, British Columbia, Canada | Recruiting |
| Winnipeg Clinic | Winnipeg, Manitoba, Canada | Recruiting |
| G.A. Research Associates Ltd. | Moncton, New Brunswick, Canada | Recruiting |
| Centricity Research Brampton Endocrinology | Brampton, Ontario, Canada | Recruiting |
| Centricity Clinical Research Burlington | Burlington, Ontario, Canada | Completed |
| Centricity Research Vaughn Endocrinology | Concord, Ontario, Canada | Recruiting |
| Medical Trust Clinics, Inc. | Courtice, Ontario, Canada | Completed |
| Centricity Research Etobicoke Endocrinology | Etobicoke, Ontario, Canada | Recruiting |
| Janik Research | Greater Sudbury, Ontario, Canada | Recruiting |
| Premier Clinical Trial Research Network (PCTRN) | Hamilton, Ontario, Canada | Recruiting |
+ 63 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07112339